Editorial Board

Editor

  • Deanna M. Barch, PhD, Washington University in St Louis, Department of Psychology, Saint Louis, Missouri, United States of America

Deputy Editor

  • Paul J. Harrison, D.M., FRCPsych, University of Oxford, Department of Psychiatry, Oxford, United Kingdom

Managing Editor

  • Rhiannon Bugno

Editorial Committee

  • Carrie E. Bearden, PhD, UCLA Jane and Terry Semel Institute for Neuroscience and Human Behavior, Los Angeles, California, United States of America
  • F. Xavier Castellanos, MD, New York University, Department of Child and Adolescent Psychiatry, New York, New York, United States of America
  • Dennis S. Charney, MD, Mount Sinai School of Medicine, New York, New York, United States of America
  • David Goldman, MD, NIAAA NIH, Laboratory of Neurogenetics, Rockville, Maryland, United States of America
  • Raquel E. Gur, MD, PhD, University of Pennsylvania Medical Center, Department of Psychiatry, Philadelphia, Pennsylvania, United States of America
  • Cynthia Rogers, MD, Washington University School of Medicine in St. Louis, Department of Psychiatry, Saint Louis, Missouri, United States of America

Ex-Officio Committee

  • Judith Ford, PhD
  • David A. Lewis, MD
  • Scott L. Rauch, MD

Editor-in-Chief, SOBP Publications

  • John H. Krystal, MD, Yale University, School of Medicine, Department of Psychiatry, New Haven, Connecticut, United States of America

Editorial Board

  • Ana Cristina Andreazza, Pharm, PhD, University of Toronto, Departments of Pharmacology & Toxicology and Psychiatry, Toronto, Ontario, Canada, Bipolar disorder,  Mood disorders,  Oxidative stress,  Mitochondrial function,  Brain health
  • Celso Arango, MD, PhD, Universidad Complutense de Madrid, Hospital General Universitario Gregorio Marañon, Madrid, Spain, Neuroimaging
  • Carlos A. Bolaños-Guzmán, PhD, Texas A&M University, Department of Psychological and Brain Sciences, College Station, Texas, United States of America
  • Geraldo Filho Busatto, MD, PhD, University of Sao Paulo, Department of Psychiatry, Sao Paulo, Brazil
  • Mary Cannon, PhD, Royal College of Surgeons in Ireland, Department of Psychiatry, Dublin, Ireland
  • Raymond Chan, PhD, Institute of Psychology Chinese Academy of Sciences, Beijing, China, Neuroimaging, Affective Cognitive Neuroscience, Neuropsychology, Transdiagnostic approach
  • Erika Comasco, MPharm, PhD, Uppsala University, Department of Neuroscience, Uppsala, Sweden
  • John Cryan, PhD, University College Cork, Cork, Ireland, Stress, Microbiome, Neuroimmunology
  • Michael Davidson, MD, University of Nicosia Medical School, Lefkosia, Cyprus, Psychopathology
  • Smita Deshpande, MD, DPM, Atal Bihari Vajpayee Institute of Medical Sciences and Dr. Ram Manohar Lohia Hospital, Department of Psychiatry, Bangalore, India, Schizophrenia, Autism, Dyslexia, Yoga, Genetics, Ethics, Clinical trials, Implementation, Intervention research
  • Katharina E. Domschke, MD, PhD, University of Freiburg, Department of Psychiatry and Psychotherapy, Freiburg, Germany, Genetics,  Epigenetics,  Anxiety,  Affective Disorders,  Obsessive-Compulsive Disorders
  • Damien A. Fair, PA-C, PhD, University of Minnesota, Institute of Child Development and Department of Pediatrics, Minneapolis, Minnesota, United States of America
  • Paul C. Fletcher, PhD, University of Cambridge, Department of Psychiatry, Cambridge, United Kingdom
  • Cecilia Flores, PhD, McGill University, Douglas Mental Health University Institute, Montréal, Quebec, Canada, Neurodevelopment
  • Erika E. Forbes, PhD, University of Pittsburgh, Department of Psychiatry, Pittsburgh, Pennsylvania, United States of America, Depression,  Reward,  Brain mechanisms,  Affective neuroscience,  Adolescent psychopathology,  Development
  • Clarissa S. Gama, MD, PhD, Universidade Federal do Rio Grande do Sul, Department of Psychiatry and Forensic Medicine, Porto Alegre, Rio Grande do Sul, Brazil
  • Ute Habel, PhD, Universitätsklinikum Aachen, Clinic for Psychiatry, Psychotherapy and Psychosomatics, Aachen, Germany
  • Catherine A. Hartley, PhD, New York University, Department of Psychology, New York, New York, United States of America
  • Andreas Heinz, MD, PhD, Charité – Universitätsmedizin Berlin,, Department of Psychiatry and Psychotherapy, Berlin, Germany, Addictions,  Schizophrenia
  • Oliver D. Howes, DM, PhD, National Institute for Health Research Maudsley Biomedical Research Centre, London, United Kingdom, Pharmacology
  • Kazutaka Ikeda, PhD, Tokyo Metropolitan Institute of Medical Science, Addictive Substance Project, Setagaya-Ku, Japan
  • Johanna M. Jarcho, PhD, Temple University, Department of Psychology, Philadelphia, Pennsylvania, United States of America
  • Evgeny Krupitsky, MD, PhD, Bekhterev National Medical Research Center for Psychiatry and Neurology, Department of Addictions, Sankt Peterburg, Russian Federation
  • Jun Soo Kwon, PhD, MD, Seoul National University, College of Medicine, Department of Neuropsychiatry, Gwanak-gu, South Korea, OCD,  High risk,  Schizophrenia
  • Jimmy Lee Chee Keong, MD, Institute of Mental Health, Singapore, Singapore, Treatment
  • Tatia Lee, PhD, The University of Hong Kong, Pokfulam Road, Hong Kong, Cognition, depression, anxiety, loneliness
  • Cathryn Lewis, PhD, King's College London, Institute of Psychiatry, Psychology and Neuroscience, London, United Kingdom
  • Carlos A. López Jaramillo, MD, PhD, University of Antioquia, Department of Psychiatry, Medellín, Colombia
  • Daniel Martins-de-Souza, PhD, University of Campinas, Laboratory of Neuroproteomics, SAO PAULO, Brazil, Proteomics, Metabolomics, Mass spectrometry, Systems biology in silico, Schizophrenia, Depression, Neurobiology
  • Colleen A. McClung, PhD, University of Pittsburgh Center for Neuroscience, Pittsburgh, Pennsylvania, United States of America, Molecular mechanisms
  • Mitul A. Mehta, PhD, King's College London, Departments of Neuroimaging and Psychopharmacology, London, United Kingdom
  • Euripides Constantino Miguel, MD, PhD, University of Sao Paulo, Department of Psychiatry, Sao Paulo, Brazil
  • Gemma Modinos, PhD, King's College London, Institute of Psychiatry, Psychology and Neuroscience, London, United Kingdom
  • Bita Moghaddam, PhD, Oregon Health & Science University, Department of Behavioral Neuroscience, Portland, Oregon, United States of America
  • Robin Nusslock, PhD, Northwestern University, Evanston, Illinois, United States of America, Neuroimaging
  • Danielle Posthuma, PhD, Vrije Universiteit Amsterdam, Department of Complex Trait Genetics, Amsterdam, Netherlands
  • Trevor W. Robbins, PhD, University of Cambridge Behavioural and Clinical Neuroscience Institute, Cambridge, United Kingdom, Cognitive Neuroscience, Behavioural Neuroscience, Neuropsychopharmacology, Prefrontal cortex function Cortico-striatal systems
  • Giovanni A. Salum, MD, PhD, Universidade Federal do Rio Grande do Sul,, Department of Psychiatry, Porto Alegre, Rio Grande do Sul, Brazil
  • Jai L. Shah, MD, McGill University, Douglas Hospital Research Centre, Montréal, Quebec, Canada, Neurobiology
  • Yongyong Shi, PhD, Shanghai Jiao Tong University Bio-X Institute, Shanghai, China, Psychiatric Genetics, Neuroscience, Genetic Etiology of Complex Traits, Synthetic Genomics
  • Vikaas S. Sohal, MD, PhD, University of California San Francisco, Department of Psychiatry and Weill Institute for Neurosciences, San Francisco, California, United States of America
  • Heike Tost, MD, PhD, Central Institute of Mental Health, Department of Psychiatry and Psychotherapy, Mannheim, Germany
  • Elizabeth M. Tunbridge, PhD, University of Oxford, Department of Psychiatry, Oxford, United Kingdom
  • Odile Van den Heuvel, PhD, MD, Amsterdam UMC, Department of Anatomy & Neuroscience, Amsterdam, Netherlands, Obsessive-Compulsive Disorder,  Anxiety,  Transcranial Magnetic Stimulation,  Parkinson's Disease,  Neuroimaging
  • Valerie Voon, MD, PhD, University of Cambridge Behavioural and Clinical Neuroscience Institute, Cambridge, United Kingdom, Neuroimaging
  • Xiaoping Wang, MD, PhD, The Second Xiangya Hospital of Central South University, Department of Psychiatry, Changsha, China
  • Lars T. Westlye, PhD, University of Oslo, Department of Psychology, Oslo, Norway
  • Til Wykes, PhD, King's College London, Institute of Psychiatry, Psychology and Neuroscience, London, United Kingdom, Schizophrenia,  Mental health,  Psychosocial treatment,  Clinical trials,  Service evaluation
  • Jared W. Young, PhD, University of California San Diego, Department of Psychiatry, La Jolla, California, United States of America

Editorial Assistant

  • Lori Stoltz